Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

12 Health Care Stocks Moving In Tuesday's Intraday Session

Author: Benzinga Insights | March 19, 2024 01:31pm

Gainers

  • Ontrak (NASDAQ:OTRK) shares increased by 97.6% to $0.38 during Tuesday's regular session. The market value of their outstanding shares is at $10.3 million.
  • Fusion Pharmaceuticals (NASDAQ:FUSN) stock moved upwards by 97.41% to $21.0. The company's market cap stands at $1.5 billion.
  • SCWorx (NASDAQ:WORX) stock rose 70.74% to $3.21. The market value of their outstanding shares is at $3.8 million.
  • Enliven Therapeutics (NASDAQ:ELVN) stock increased by 29.19% to $16.33. The company's market cap stands at $675.2 million. The company's, Q4 earnings came out 3 days ago.
  • Vincerx Pharma (NASDAQ:VINC) stock rose 28.31% to $6.3. The market value of their outstanding shares is at $134.6 million.
  • NKGen Biotech (NASDAQ:NKGN) shares moved upwards by 26.9% to $2.5. The market value of their outstanding shares is at $54.7 million.

Losers

  • Acutus Medical (NASDAQ:AFIB) stock declined by 26.5% to $0.19 during Tuesday's regular session. The market value of their outstanding shares is at $5.6 million.
  • Seelos Therapeutics (NASDAQ:SEEL) stock fell 25.91% to $0.68. The market value of their outstanding shares is at $9.3 million.
  • Lantern Pharma (NASDAQ:LTRN) stock declined by 19.38% to $8.03. The company's market cap stands at $86.2 million. As per the news, the Q4 earnings report came out yesterday.
  • Eyenovia (NASDAQ:EYEN) stock fell 18.31% to $1.25. The company's market cap stands at $55.1 million. As per the news, the Q4 earnings report came out yesterday.
  • Genprex (NASDAQ:GNPX) stock decreased by 16.88% to $3.4. The market value of their outstanding shares is at $5.0 million.
  • Acurx Pharmaceuticals (NASDAQ:ACXP) stock decreased by 15.84% to $2.18. The company's market cap stands at $30.0 million. As per the press release, Q4 earnings came out yesterday. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Posted In: ACXP AFIB ELVN EYEN FUSN GNPX LTRN NKGN OTRK SEEL VINC WORX


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist